- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT00727935
Comparison Of The Analgesia Obtained By Infiltration For The Joinings Of Episiotomies (Liropep) (LiRoPep)
Comparison Of The Analgesia Obtained By Infiltration Of Lidocaïne 1% And Ropivacaïne 0,75% Versus Placebo For The Joinings Of Episiotomies Among Parturients Under Epidural Analgesia
Lateral episiotomy is a current care practiced with childbirth room. One of the problems encountered with this surgical act is the residual pain on perineal scar level. Maximal during the first 24 hours, this pain can persist several days or several weeks hampering to variable degrees a normal recovery of autonomy and comfort of life. Some studies have shown the interest of ropivacaine, local anaesthetic with a long action's duration for proctologic surgeries and for the cure of inguinal hernia. A recent study shown the ropivacaine perineal infiltration used prior perineorrhaphy allows an absence of post-partum pain for 24 to 27% of cases and a first analgesics request delayed to ten hours.
Methodology: 165 parturients having an epidural analgesia and an episiotomy were enrolled. The perineal infiltration was randomized according to 3 equal groups (placebo, ropivacaine 0,75%, lidocaine 1%) and realised prior perineorrhaphy. then The parturient were followed during the 24 first hours. This study was designed as double blind and the study conduct was standardized in order to get only variable such as the episiotomy infiltration.
Studienübersicht
Status
Intervention / Behandlung
Studientyp
Einschreibung (Tatsächlich)
Phase
- Phase 4
Kontakte und Standorte
Studienorte
-
-
Pays-de-la-Loire
-
Angers, Pays-de-la-Loire, Frankreich, 49933
- Centre Hospitalier Universitaire
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Pre-inclusion criteria :
- Assent of participation in the study signed
- Major parturient (> 18 years) in the course of work in room of childbirth
- Mono-foetal pregnancy
- Presentation at the top
Inclusion Criteria:
- Checking of the criteria of pre-inclusion
- Oral confirmation of the assent of the patient
- ASA 1 or 2
- Childbirth by low way
- Patient having an epidural analgesia
- Patient having an episiotomy
- Counter-indication with the ropivacaïne
Pre-exclusion criteria :
- Absence of signed assent of participation in the study
- Counter indication with the lidocaïne
- General counter-indications suitable for the epidural anaesthesia , independently of the local anaesthetic used
- Counter-indications with the infiltration: patient under anticoagulants, coagulopathy
- Allergy to the lidocaine or the ropivacaine
- Allergy to the one of analgesics per bones used in the assumption of responsibility of routine
- Severe insufficiency hepatic and/or renal and/or ulcerates gastro-duodénal (in the case of anti-inflammatory drug regulation not steroid during the postpartum)
- Minor
- Major protected within the meaning of the law Huriet
- Patient during one time of exclusion following another biomedical study
Exclusion Criteria:
- Absence of oral confirmation of the assent of the patient
- Infection or ignition of the point of puncture
- Analgesia epidural not functional
- Dural breach
- Appearance of ascribable side effects to only the anaesthetic buildings at the time of epidural analgesia
- Median Episiotomy (increased risk of lesions of the sphincter)
- Need for an instrumentation at the time of expulsion
- Haemorrhage of the delivery requiring a blood transfusion and/or general anaesthesia in urgency with surgical operation for haemostasis
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Verhütung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Doppelt
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Zeitfenster |
---|---|
Time between the infiltration of the local anaesthetic and the first analgesics catch per os, which is managed when the level of pain evaluated by EVA is higher than 30 mm
Zeitfenster: 1 year
|
1 year
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Zeitfenster |
---|---|
To compare between the 3 groups the mean level of the pain during the first 24 hours following the joining of the episiotomy, measured by EVA
Zeitfenster: 24 hours
|
24 hours
|
To compare between the 3 groups the analgesics overall consumption per os during the first 24 hours following the joining of the episiotomy
Zeitfenster: 24 hours
|
24 hours
|
To compare between the 3 groups the total cost of the analgesics consumption (local anaesthetic employed and analgesics per bone) during the first 24 hours following the joining of the episiotomy
Zeitfenster: 24 hours
|
24 hours
|
Mitarbeiter und Ermittler
Sponsor
Ermittler
- Hauptermittler: Laurent Colbus, MD, Centre Hospitalier Universitaire Angers
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn
Primärer Abschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Schätzen)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Schätzen)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
- Physiologische Wirkungen von Arzneimitteln
- Molekulare Mechanismen der pharmakologischen Wirkung
- Anti-Arrhythmie-Mittel
- Depressiva des zentralen Nervensystems
- Agenten des peripheren Nervensystems
- Agenten des sensorischen Systems
- Anästhetika
- Membrantransportmodulatoren
- Anästhetika, lokal
- Spannungsgesteuerte Natriumkanalblocker
- Natriumkanalblocker
- Lidocain
- Ropivacain
Andere Studien-ID-Nummern
- CHU P 2006-03
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Placebo
-
SamA Pharmaceutical Co., LtdUnbekanntAkute Bronchitis | Akute Infektion der oberen AtemwegeKorea, Republik von
-
National Institute on Drug Abuse (NIDA)AbgeschlossenCannabiskonsumVereinigte Staaten
-
AstraZenecaParexel; Spandauer Damm 130; 14050; Berlin, GermanyAbgeschlossenMännliche Probanden mit Typ-II-Diabetes (T2DM)Deutschland
-
Instituto de Investigación Hospital Universitario...Creaciones Aromáticas Industriales, S.A. (CARINSA)Abgeschlossen
-
Soroka University Medical CenterAbgeschlossen
-
Regado Biosciences, Inc.AbgeschlossenGesunder FreiwilligerVereinigte Staaten
-
Texas A&M UniversityNutraboltAbgeschlossenGlucose and Insulin Response
-
Longeveron Inc.BeendetHypoplastisches LinksherzsyndromVereinigte Staaten
-
Heptares Therapeutics LimitedAbgeschlossenPharmakokinetik | SicherheitsproblemeVereinigtes Königreich